{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:34:23Z","timestamp":1779114863143,"version":"3.51.4"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084604","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T22:39:22Z","timestamp":1387406362000},"page":"e84604","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["BRAFV600E Mutation Analysis in Patients with Metastatic Colorectal Cancer (mCRC) in Daily Clinical Practice: Correlations with Clinical Characteristics, and Its Impact on Patients\u2019 Outcome"],"prefix":"10.1371","volume":"8","author":[{"given":"Zacharenia","family":"Saridaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tzardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Sfakianaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chara","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Voutsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristea","family":"Kalykaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippokratis","family":"Messaritakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriakos","family":"Mpananis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Mavroudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathios","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Souglakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref2"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2008.18.0786","article-title":"Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer","volume":"26","author":"F Di Nicolantonio","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-07-1489","article-title":"Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer","volume":"14","author":"AJ French","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2008.155473","article-title":"CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer","volume":"58","author":"S Ogino","year":"2009","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-05-0404","article-title":"Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers","volume":"65","author":"WS Samowitz","year":"2005","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e15980","DOI":"10.1371\/journal.pone.0015980","article-title":"Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in >\/= 2 line cetuximab-based therapy of colorectal cancer patients","volume":"6","author":"Z Saridaki","year":"2011","journal-title":"PLOS ONE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.bjc.6605164","article-title":"Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer","volume":"101","author":"J Souglakos","year":"2009","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1038\/sj.onc.1207061","article-title":"BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency","volume":"22","author":"C Oliveira","year":"2003","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/418934a","article-title":"Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status","volume":"418","author":"H Rajagopalan","year":"2002","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/sj.bjc.6605694","article-title":"BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome","volume":"102","author":"Z Saridaki","year":"2010","journal-title":"Br J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jmg.2004.020651","article-title":"BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing","volume":"41","author":"E Domingo","year":"2004","journal-title":"J Med Genet"},{"key":"ref13","first-page":"5209","article-title":"BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair","volume":"63","author":"L Wang","year":"2003","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial","volume":"28","author":"AD Roth","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2011.39.5814","article-title":"Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer","volume":"30","author":"V Popovici","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"W De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.bjc.6605177","article-title":"KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer","volume":"101","author":"F Loupakis","year":"2009","journal-title":"Br J Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJMc0904160","article-title":"BRAF mutation in metastatic colorectal cancer","volume":"361","author":"J Tol","year":"2009","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","article-title":"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status","volume":"29","author":"E Van Cutsem","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2353\/jmoldx.2006.060070","article-title":"Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology","volume":"8","author":"S Benlloch","year":"2006","journal-title":"J Mol Diagn"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2407-13-49","article-title":"Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS\/RAF, PIK3CA genotypes","volume":"13","author":"G Pentheroudakis","year":"2013","journal-title":"BMC Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1200\/jco.2013.31.15_suppl.3511","article-title":"Analysis of KRAS\/NRAS and BRAF mutations in the phase III PRIME study of panitumumab (pmab) plus FOLFOX versus FOLFOX as first-line treatment (tx) for metastatic colorectal cancer (mCRC)","volume":"31","author":"KS Oliner","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature04304","article-title":"BRAF mutation predicts sensitivity to MEK inhibition","volume":"439","author":"DB Solit","year":"2006","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making","volume":"23","author":"HJ Schmoll","year":"2012","journal-title":"Ann Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T12:49:06Z","timestamp":1597236546000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084604"}},"subtitle":[],"editor":[{"given":"Rui\u00a0Manuel","family":"Reis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084604","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}